HIGHLIGHTS
- who: Toshiro Hirai from the Research Initiatives, Osaka University, Suita, Japan, Vaccine Creation Group, BIKEN Innovative Vaccine Research Alliance have published the research work: Considerations of CD8+ T Cells for Optimized Vaccine Strategies Against Respiratory Viruses, in the Journal: (JOURNAL)
- what: The focus of this review is to overview recent concepts related to CD8 + T_cells, and the authors have intentionally omitted a discussion on T_cell markers and the molecular mechanism of their induction/maintenance to appeal to a broader audience. and they hence constitute a high-risk group for respiratory infection with severe disease, including . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.